China SXT Pharmaceuticals closes $12 million registered offering

China SXT Pharmaceuticals Inc. successfully completed a $12 million registered direct offering of Class A ordinary shares, with 8,000,000 shares sold to institutional investors at $1.50 per share. The offering included 8,000,000 warrants, each exercisable immediately and with a one-year term, allowing holders to acquire up to nine Class A shares each.

Univest Securities, LLC served as the sole placement agent for the transaction, which was conducted under a shelf registration statement filed on December 1, 2025. China SXT Pharmaceuticals, based in Taizhou City, Jiangsu Province, China, specializes in researching, developing, manufacturing, marketing, and selling traditional Chinese medicine pieces.

Brief written by urgent.news from Investing.com's own syndicated text. Machine-written — may contain errors; check the original before relying on it.